Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Manoranjan Panda"'
Autor:
Moolchand Kurmi, Vasantha Krishna Kadambar, Pavan Srinivas, Yernaidu Reddi, Manoranjan Panda, Michael Peddicord, Scott A Miller, Joel Young, Hemant Bhutani, Lakshmikant Bajpai
Publikováno v:
Journal of the American Society for Mass Spectrometry. 34:969-976
Autor:
Chunjian Liu, Prasada Rao Jalagam, Jianxin Feng, Wei Wang, Thiruvenkadam Raja, Mallikarjuna Reddy Sura, Raju K. V. L. P. Manepalli, Bheema Reddy Aliphedi, Santosh Medavarapu, Satheesh K. Nair, Vetrichelvan Muthalagu, Ramesh Natesan, Anuradha Gupta, Brett Beno, Manoranjan Panda, Kaushik Ghosh, Jinal Kaushikkumar Shukla, Harinath Sale, Priyanka Haldar, Narasimharaju Kalidindi, Devang Shah, Dipal Patel, Arvind Mathur, Bruce A. Ellsworth, Dong Cheng, Alicia Regueiro-Ren
Publikováno v:
Journal of medicinal chemistry. 65(16)
Galectin-3 (Gal-3), a member of the β-galactoside-binding protein family, is implicated in a wide variety of human diseases. Identification of Gal-3 inhibitors with the right combination of potency (against both human and mouse Gal-3) and pharmacoki
Publikováno v:
2020 International Conference on Emerging Trends in Information Technology and Engineering (ic-ETITE).
The massive technological expansions in modern healthcare solutions have substantially influenced the development of several unfolding research fields. One such interesting area involves the therapeutic prognosis of pathological conditions in patient
Publikováno v:
International Journal of Computer Sciences and Engineering. 6:1227-1233
Autor:
Manoranjan Panda, Omprakash Kar
Publikováno v:
International Journal of Engineering Trends and Technology. 48:258-268
Autor:
Vijender Panduga, Manoranjan Panda, Radha Shandil, Shridhar Narayanan, Naveen Kumar, M Sreenivasaiah, Monalisa Chatterji, Pravin S. Shirude, Claire Sadler, Vasan K. Sambandamurthy, Tommasi Ruben A, Supreeth Guptha, Jyothi Mahadevaswamy, Meenakshi Mallya, Pravin Iyer, Sreevalli Sharma, Vasanthi Ramachandran, Christopher B. Cooper, Anisha Ambady, Ashwini Narayan, Manjunatha M R, Khisi Mdluli, Scott Butler
Publikováno v:
ACS Med Chem Lett
[Image: see text] We report a novel benzimidazole (BI) based DprE1 inhibitor that resulted from scaffold morphing of a 1,4-azaindole series. The clinical progression of the 1,4-azaindole series from our previous work validates the potential of explor
Autor:
Pravin Iyer, Manoranjan Panda
Publikováno v:
Lead Generation
Autor:
Manoranjan Panda, Anandkumar Raichurkar, Neela Dinesh, Vinayak Hosagrahara, Naveen Kumar, K.R. Prabhakar, Suresh Rudrapatna, Gayathri Balakrishnan, Amit K. Gupta, Vasan K. Sambandamurthy, Karthikeyan Kandaswamy, Stefan Kavanagh, Ramanatha Saralaya, Lalit kumar Jena, Shridhar Narayanan, Suresh Solapure, Robert Nanduri, V. Balasubramanian, Meenakshi Mallya, Ashwini Narayan, Sowmya Bharath, Vijender Panduga, Vikas Shinde, Jitendar Reddy, Khisi Mdluili, Christopher B. Cooper, Parvinder Kaur, Shahul Hameed P, Sreevalli Sharma, Supreeth Guptha, Kakoli Mukherjee, Sudha Ravishankar, Radha Shandil, Pravin Iyer, Shankar D. Markad, Vasanthi Ramachandran, Takahiro Yano, Jyothi Bhat, Harvey Rubin, Subramanyam J. Tantry
Publikováno v:
MedChemComm. 7:1022-1032
The success of bedaquiline as an anti-tubercular agent for the treatment of multidrug-resistant tuberculosis has validated the ATP synthesis pathway and in particular ATP synthase as an attractive target. However, limitations associated with its use
Autor:
Vaishali Humnabadkar, Claire Sadler, Tanjore S. Balganesh, Prakash Vachaspati, Disha Awasthy, Manoranjan Panda, Mick D. Fellows, Parvinder Kaur, Stewart T. Cole, Florence Pojer, Vasan K. Sambandamurthy, João Neres, Sreevalli Sharma, V. Balasubramanian, Kannan Murugan, Meenakshi Mallya, Suresh Rudrapatna, Balachandra Bandodkar, Sudhir Landge, Bheemarao G. Ugarkar, Jyothi Mahadevaswamy, Kavitha Nagalapur, Amrita B. Mullick, Vasanthi Ramachandran, Anirban Ghosh, Venkita Subbulakshmi
Publikováno v:
Bioorganic & Medicinal Chemistry. 23:7694-7710
We report the discovery of benzothiazoles, a novel anti-mycobacterial series, identified from a whole cell based screening campaign. Benzothiazoles exert their bactericidal activity against Mycobacterium tuberculosis (Mtb) through potent inhibition o
Autor:
Parvinder Kaur, Shankar D. Markad, B. K. Kishore Reddy, Manoranjan Panda, Murugan Chinnapattu, Radha Nandishaiah, Anandkumar Raichurkar, Pravin Iyer
Publikováno v:
Medicinal Chemistry Research. 24:2986-2992
The key to shortening tuberculosis (TB) drug regimen lies in eliminating the reservoir of non-replicating persistent (NRP) Mycobacterium tuberculosis (Mtb). Pyrazinamide (PZA) is the only known drug used as part of a combination therapy that is belie